256 related articles for article (PubMed ID: 36759234)
21. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
[TBL] [Abstract][Full Text] [Related]
22. [Gastroenterological manifestations of von Hippel-Lindau disease].
Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
Pol Merkur Lekarski; 2017 Aug; 43(254):53-55. PubMed ID: 28875969
[TBL] [Abstract][Full Text] [Related]
23. Sunitinib treatment of metastatic renal cell carcinoma in von Hippel-Lindau disease.
Tsimafeyeu I
J Cancer Res Ther; 2015; 11(4):920-2. PubMed ID: 26881543
[TBL] [Abstract][Full Text] [Related]
24. [Sarcomatoid renal cell carcinoma with von Hippel-Lindau disease: a case report].
Minagawa T; Nishizawa S; Kamigaito M; Nakayama T; Okaneya T
Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):723-6. PubMed ID: 17682453
[TBL] [Abstract][Full Text] [Related]
25. EUS-guided FNA cytology of pancreatic neuroendocrine tumour (PanNET): a retrospective study of 132 cases over an 18-year period in a single institution.
Chen S; Lin J; Wang X; Wu HH; Cramer H
Cytopathology; 2014 Dec; 25(6):396-403. PubMed ID: 24635775
[TBL] [Abstract][Full Text] [Related]
26. Single case of renal cell carcinoma and endocrine pancreatic head cancer occurring with von Hippel-Lindau disease.
Osawa A; Sumiyama Y; Watanabe M; Tanaka H; Asai K; Enomoto T; Matsukiyo H; Kanai R; Takeuchi Y; Oharazeki T
J Hepatobiliary Pancreat Surg; 2006; 13(2):174-80. PubMed ID: 16547682
[TBL] [Abstract][Full Text] [Related]
27. MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma.
Hasanov E; Jonasch E
Expert Opin Investig Drugs; 2021 May; 30(5):495-504. PubMed ID: 33945366
[TBL] [Abstract][Full Text] [Related]
28. Endocrine manifestations of von Hippel-Lindau disease.
Cassol C; Mete O
Arch Pathol Lab Med; 2015 Feb; 139(2):263-8. PubMed ID: 25611110
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.
Tamura K; Nishimori I; Ito T; Yamasaki I; Igarashi H; Shuin T
World J Gastroenterol; 2010 Sep; 16(36):4515-8. PubMed ID: 20857520
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma.
Kim WT; Ham WS; Ju HJ; Lee JS; Lee JS; Choi YD
J Korean Med Sci; 2009 Dec; 24(6):1145-9. PubMed ID: 19949673
[TBL] [Abstract][Full Text] [Related]
31. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.
Hammel PR; Vilgrain V; Terris B; Penfornis A; Sauvanet A; Correas JM; Chauveau D; Balian A; Beigelman C; O'Toole D; Bernades P; Ruszniewski P; Richard S
Gastroenterology; 2000 Oct; 119(4):1087-95. PubMed ID: 11040195
[TBL] [Abstract][Full Text] [Related]
33. Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease.
Gucer H; Szentgyorgyi E; Ezzat S; Asa SL; Mete O
Virchows Arch; 2013 Oct; 463(4):593-7. PubMed ID: 23913169
[TBL] [Abstract][Full Text] [Related]
34. Von Hippel-Lindau Disease With Multi-Organ Involvement: A Case Report and 8-Year Clinical Course With Follow-Up.
Yaghobi Joybari A; Azadeh P
Am J Case Rep; 2017 Nov; 18():1220-1224. PubMed ID: 29146893
[TBL] [Abstract][Full Text] [Related]
35. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic neuroendocrine tumors in French VHL mutation carriers: a multicentric retrospective study.
Muller M; Hammel P; Couvelard A; Védie AL; Cros J; Burnichon N; Hercent A; Sauvanet A; Richard S; de Mestier L
J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38706378
[TBL] [Abstract][Full Text] [Related]
37. Two Childhood Pheochromocytoma Cases due to von Hippel-Lindau Disease, One Associated with Pancreatic Neuroendocrine Tumor: A Very Rare Manifestation.
Dağdeviren Çakır A; Turan H; Aykut A; Durmaz A; Ercan O; Evliyaoğlu O
J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):179-182. PubMed ID: 29022557
[TBL] [Abstract][Full Text] [Related]
38. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic neuroendocrine tumor with complete replacement of the pancreas by serous cystic neoplasms in a patient with von Hippel-Lindau disease: a case report.
Maeda S; Motoi F; Oana S; Ariake K; Mizuma M; Morikawa T; Hayashi H; Nakagawa K; Kamei T; Naitoh T; Unno M
Surg Case Rep; 2017 Sep; 3(1):105. PubMed ID: 28948530
[TBL] [Abstract][Full Text] [Related]
40. Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.
Jilg CA; Neumann HP; Gläsker S; Schäfer O; Leiber C; Ardelt PU; Schwardt M; Schultze-Seemann W
Fam Cancer; 2012 Sep; 11(3):387-94. PubMed ID: 22426863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
